These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23973239)

  • 1. Thin catheter surfactant administration during spontaneous breathing in very low birth weight infants is associated with reduced need for mechanical ventilation.
    Benjamin J; Wright CJ
    J Pediatr; 2013 Sep; 163(3):923-4. PubMed ID: 23973239
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial.
    Kanmaz HG; Erdeve O; Canpolat FE; Mutlu B; Dilmen U
    Pediatrics; 2013 Feb; 131(2):e502-9. PubMed ID: 23359581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data.
    Kribs A; Härtel C; Kattner E; Vochem M; Küster H; Möller J; Müller D; Segerer H; Wieg C; Gebauer C; Nikischin W; Wense Av; Herting E; Roth B; Göpel W
    Klin Padiatr; 2010; 222(1):13-7. PubMed ID: 20084586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome.
    Duman N; Tüzün F; Sever AH; Arslan MK; İşcan B; Dilek M; Kumral A; Ozkan H
    J Matern Fetal Neonatal Med; 2016; 29(2):252-7. PubMed ID: 25491882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
    Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
    Trials; 2016 Aug; 17():414. PubMed ID: 27538798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
    Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
    Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorespiratory Physiology following Minimally Invasive Surfactant Therapy in Preterm Infants.
    Sehgal A; Bhatia R; Roberts CT
    Neonatology; 2019; 116(3):278-285. PubMed ID: 31487729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation.
    Dargaville PA; Ali SKM; Jackson HD; Williams C; De Paoli AG
    Neonatology; 2018; 113(1):7-14. PubMed ID: 28922658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study.
    Jourdain G; Zacaria F; Ammar F; De Luca D
    Arch Dis Child Fetal Neonatal Ed; 2016 Mar; 101(2):F182-3. PubMed ID: 26785859
    [No Abstract]   [Full Text] [Related]  

  • 11. Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
    Rey-Santano C; Mielgo VE; Gomez-Solaetxe MA; Bianco F; Salomone F; Loureiro B
    Crit Care Med; 2020 Jun; 48(6):e523-e531. PubMed ID: 32301841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants?
    Kribs A
    J Perinatol; 2009 Mar; 29(3):256. PubMed ID: 19240733
    [No Abstract]   [Full Text] [Related]  

  • 13. Supraglottic Atomization of Surfactant in Spontaneously Breathing Lambs Receiving Continuous Positive Airway Pressure.
    Milesi I; Tingay DG; Lavizzari A; Bianco F; Zannin E; Tagliabue P; Mosca F; Ventura ML; Rajapaksa A; Perkins EJ; Black D; Di Castri M; Sourial M; Pohlmann G; Dellaca' RL
    Pediatr Crit Care Med; 2017 Sep; 18(9):e428-e434. PubMed ID: 28742723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Search for Treatment of Bronchopulmonary Dysplasia.
    Jobe A
    JAMA Pediatr; 2016 Apr; 170(4):322-4. PubMed ID: 26928031
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
    More K; Sakhuja P; Shah PS
    JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of a new technique of minimally invasive surfactant therapy.
    Dargaville PA; Aiyappan A; Cornelius A; Williams C; De Paoli AG
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F243-8. PubMed ID: 20971722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in hemodynamics after rescue surfactant administration.
    Katheria AC; Leone TA
    J Perinatol; 2013 Jul; 33(7):525-8. PubMed ID: 23328925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.